EFMC
ICCC icon

Empire Financial Management Company’s ImmuCell ICCC Stock Holding History

Empire Financial Management Company’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-42,000
Closed -$210K – 196
2023
Q2 		$210K Hold
42,000
– – 0.08% 189
2023
Q1 		$215K Buy
+42,000
New +$273K 0.09% 187

Other funds holding ICCC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Empire Financial Management Company's ICCC Position: Q3 2023 in Review

Empire Financial Management Company sold out of ImmuCell (ICCC) in Q3 2023, closing a stake of 42,000 shares — an estimated $210K sold.

Empire Financial Management Company first reported a position in ICCC in Q1 2023 and held it in 2 quarters. The position peaked at $215K in Q1 2023. 30 funds tracked by Wall St. Rank hold ICCC as of Q3 2023.

  • Empire Financial Management Company reported no remaining ImmuCell position as of Q3 2023 after selling out during the quarter.
  • Empire Financial Management Company sold 42,000 ImmuCell shares in Q3 2023, an estimated $210K.
  • Empire Financial Management Company first reported a position in ImmuCell in Q1 2023 and held it in 2 quarters.
  • Empire Financial Management Company's ImmuCell position peaked at $215K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held ImmuCell as of Q3 2023.

Based on Empire Financial Management Company's 13F filing for Q3 2023, filed 13 Nov 2023.